6 Billion CFU Probiotics Featuring resilient Bacillus strains including DE111 Bacillus subtilis and MuniSpore Bacillus clausii that support balanced gut microbiome and healthy digestive functionimportant for maintaining comfort during calorie reduction
FDA Mller TD, Blher M, Tschp MH, DiMarchi RD
The whole situation becomes a real Catch-22 situation
People will still have options, Conti added
Jamilian H, Jamilian M, Samimi M, et al
Heres what it means for Medicaid enrollees: Medicaid access through the BALANCE Model could begin as early as May 2026 States must opt in voluntarily its not automatic Participating states receive federally negotiated prices from Eli Lilly (Zepbound, Mounjaro) and Novo Nordisk (Wegovy, Ozempic) Wegovy and Zepbound starting doses would cost the program $350/month (reduced from over $1,000) Patients in participating states would pay $50/month for covered GLP-1s Prior authorization and qualifying criteria will still apply This is the biggest potential expansion of GLP-1 access for Medicaid enrollees in history but it depends on your state deciding to participate
